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2Summary
We show in this review that there is a continuum between the chicken B cell system
classified as the first GALT model described and the human B cell system. We propose
that humans have conserved for one B-cell subpopulation, the marginal zone B-cell subset
in charge of T-independent responses, the strategies of diversification used by GALT
species to generate their pre-immune repertoire.
3When the chicken model of B cell development was described at the molecular
level, it provided a different version of the GOD’s (generation of diversity) solution,
introducing gut-associated lymphoid tissues (GALT) as the site where the all pre-immune
B cell repertoire is produced by post-rearrangement diversification processes1.
At that time the GOD’s enigma seemed more or less solved by the mouse model
which had showed that Ig diversity was generated by the « roulette of rearrangement »: a
few hundred V genes recombining to a small number of D and/or J elements in a random
fashion, allowing the generation throughout life in the bone marrow of an infinite number
of B cells, each of them carrying theoretically a different Ig receptor2.
In the chicken several steps appeared strikingly different3:
1) Rearrangement is used to produce a quasi-monoclonal population of B cells, each of
them having rearranged a unique functional VH-VL pair.
2) Ig gene rearrangement occurs during a short period of time during embryonic
development and targets a few million progenitors. A few hundred thousands B cell
progenitors having performed a productive H-L rearrangement localize in the epithelium
of the bursa of Fabricius and proliferate within bursal follicles (10,000 follicles with 1-10
founder cells). A few days before hatching and several weeks after, bursal B cells start to
migrate to the periphery, generating the B cell compartment of the animal.
3) Diversity is generated on this VH-VL pair by ongoing gene conversion involving
upstream pseudogenes, starting during embryonic development and thereafter during the
first months of life in the bursa, a primary lymphoid organ that involutes and disappears
around 6 months after hatching.
GALT models of B cell development were further discovered in mammalian species
with the molecular description of the sheep and rabbit B cell immune system (table 1). The
search for a « mammalian bursa» had been the goal of the pioneers who described the
chicken immune system. Their first choice was the rabbit (rightfully, see below), having
shown that removal at birth of appendix and other GALT (Sacculus rotundus and Peyer’s
patches) reduced considerably the B cell response in this species4. However at the same
time, it was shown that, in the mouse and human models, transfer of bone marrow
precursors could restore the B cell lineage of the receiver5,6. The description of an
ontogenetic process leading to the generation of B cells in the mouse bone marrow
consolidated further the model and the idea of a mammalian bursa-equivalent was
abandoned7.
4Bursa-equivalent primary organs in mammals
In readdressing the question of the existence of a mammalian bursa, we were
motivated by the work of Reynolds and Morris who showed that Peyer’s patches were of
two sorts in sheep: the ileal Peyer ‘s patches, which morphologically and functionally
behaved like a primary lymphoid organ, and the jejunal Peyer’s patches, which on the
contrary possessed all the properties of secondary lymphoid organs8.
The study of the light chain locus during development indeed showed that the
sheep used its ileal Peyer’s patches to generate its B cell pre-immune repertoire with
similarities and differences with the chicken model9,10.
1) Rearrangement occurs in sheep during a short window of development during fetal life,
mostly in the fetal liver and in the spleen. The light chain lambda locus (the major light
chain isotype) contains around 100 genes among which approximately half are functional,
but 2 Vλ  genes contribute 50% of the rearrangements. A few million cells having
performed a productive rearrangement reach the ileal epithelium during fetal life and
induce the formation of 100,000 follicles in which they proliferate for several months after
birth.
2) During proliferation in ileal Peyer’s patch follicles, all B cells diversify their Ig receptor
by somatic hypermutation, the very process used by most species during affinity
maturation for the response to T-dependent (TD) antigens.
3) Similarly to what occurs in the chicken, Ig diversification starts in the antigen-free
environment of the embryo and goes on for several months after birth as an antigen- and
T-independent process. Diversified B cells migrate to the periphery and install the B cell
compartment for the whole life of the animal. Ileal Peyer’s patches involute and
completely disappear after one year while the jejunal Peyer’s patches remain throughout
life.
The rabbit model was shown by the group of K. Knight to be another variation on
the GALT theme, confirming that this mode of B cell development had been conserved in
the mammalian kingdom. At the genomic level, the heavy chain locus was very « mouse-
like », as it includes a large family of functional VH genes, but all VH genes, as in the
chicken, belong to a single VH family (VH3). Instead of rearranging at the same frequency
anyone of these genes, the most proximal VH1 gene is rearranged in 80% of its B cells. This
VH gene is thereafter diversified by a « chicken-like » ongoing gene conversion process
involving upstream functional or non-functional VH genes while the CDR3 region is
diversified by a« sheep-like » hypermutation mechanism11.  As in the chicken,
rearrangement occurs essentially during early development while diversification by gene
5conversion occurs mainly in appendix follicles12. Contrarily to the chicken and to the
sheep, B cell proliferation and diversification only start after birth and the GALT remain
once the B cell compartment is installed after 2-3 months, shifting their activities from that
of a primary organ of diversification to that of a secondary lymphoid organ with clear
germinal centers involved in T-dependent immune responses.
As for the lymphoid organs in which these events take place, we have proposed, on
the basis of experiments performed on germ free sheep and on ileal loops realized on fetal
sheep, that gut bacterial constituents essentially provide the B cells present in follicles with
a proliferative signal rather than with an antigenic stimuli10. A similar proposition was
recently formulated for the rabbit model in which it was shown that it is the presence of
these bacterial constituents in the gut that permits the initiation of this proliferative phase
in the GALT, most probably again due to their mitotic enhancement capacity13,14. It is
therefore tempting to associate at the evolutionary level these post-rearrangement
diversification processes requiring many cycles of proliferation and selection with an
organ in which this proliferation can be naturally maintained. Others GALT models have
since been described, in cattle, pigs, dogs, and it is highly probable that a large number of
mammalian species uses this strategy to generate their B cell repertoire14. Another
surprising property of the GALT species is that once their B cell compartment is installed
at the periphery at the end of development, there is no more de novo production of new B
cells, implying that this peripheral compartment is sufficient to protect the animal for its
life time. How is this peripheral compartment maintained is not known at the moment. It
must be composed of memory and naive B cells but whether the latter ones can self-renew
or are maintained by a pool of progenitors with stem cell properties is an open question.
Human and mice would have thus evolved this luxury to continually produce B cells with
the possibility that any new antigen being encountered (Mel Cohn’s moon dust15) may be
taken care of by any one of these newly produced VDJ recombinations.
At the evolutionary level, whether diversity is stored in V pseudogenes or
functional genes and whether the mecanism of diversification of the pre-immune
repertoire is ongoing rearrangement or ongoing gene conversion and hypermutation does
not make much difference. In such sense the chicken and the rabbit pseudoV genes are
indeed functional donors of diversity for an acceptor V gene. Nevertheless there is a great
difference between an ongoing rearrangement process involving mainly a variability at the
CDR3 level and the variability generated on the three CDRs by gene conversion or
hypermutation. Surprisingly enough, hypermutation appears to be a fully efficient
mechanism to generate a pre-immune repertoire. This comes from two different processes:
6first, a co-evolution of the mutation mechanism and of the target V gene sequence, by
which mutation hotspots leading to replacement mutations are specifically clustered in
CDRs, thus allowing a strong concentration and a high R/S ratio of CDR mutations10,16.
Second, a constant selection for cells with a functional BCR at the surface that can provide
the appropriate tonic signal, ensuring the counter-selection of deleterious mutations in
framework regions (and a low R/S ratio of framework mutations). Both of these features
result in a mutation selection pattern very similar to the one observed during antigen-
selected immune responses10.
A T-independent diversification pathway in humans
In mice and humans, germline antibodies display a rather low affinity for their
specific antigens and show some polyspecificity. It has been proposed that this loose
specificity could be explained by the flexibility of their combining site. According to this
model, affinity maturation and selection, after encounter with its specific protein antigen,
should allow for the fixation of this antibody-combining site to its ligand, thus suppressing
its flexibility and polyspecificity17. The most obvious explanation for this strategy would
be to preserve the pre-immune repertoire from the holes of negative selection. Included in
this scheme is the fact that immune responses to non-protein antigens will only raise
germ-line antibodies responses.
In the GALT models all types of affinities will emerge from the primary repertoire and
in fact most de novo produced B cells will die in the GALT and only around 5% will
migrate to the periphery. Immune responses to proteins antigens will still be improved by
an additional diversification step in germinal centers by hypermutation and/or gene
conversion. Immune responses to T-independent antigens on the other hand will
theoretically generate high affinity responses with mutated antibodies. In human the T-
independent responses represent a paradox since they are by definition against non-
protein antigens and therefore germinal center-independent. Strikingly, antibodies raised
by T-independent vaccines such as bacterial capsular polysaccharides are usually mutated
and, to explain this paradox, it is proposed the rather unlikely scenario that these bacterial
polysaccharides in each vaccine preparation may be coated with bacterial proteins that
would drive them into a T-dependent hypermutation process in germinal centers18.
Another explanation could be that some specialized B cells may in human mutate their Ig
receptor after stimulation by T-independent antigens. A third explanation which we favor
and which does not exclude the latter one is that the B cells in charge of T-I responses in
humans already mutate their Ig receptor during their postnatal development, as it occurs
7in rabbit, before their immune response to external antigens. In this last scheme, the TI-
antigens would select for B cell clones with the best affinity in the splenic marginal zone
and induce a second round of hypermutation after stimulation.
We have come to this proposition because of the following observations19,20:
1) Hyper-IgM patients with either CD40L or CD40 deficiency, which do not have germinal
centers, possess a population of circulating IgM+IgD+CD27+ B cells with a mutated Ig
receptor, in the complete absence of CD27+ IgM-only and switched memory B cells. In
both type of patients the frequency of Ig mutations observed in these cells is very similar
to the one observed in controls although the number of IgM+IgD+CD27+ blood cells is in
general lower in the patients as compared to normal children. The absence of CD40 or
CD40L may alter B cell development by hampering the network of cytokines interactions
involving dendritic cells, activated T cells and natural killer cells. Nevertheless the fact that
these patients never display any CD27+ IgM-only B cells indicate that the IgM+IgD+CD27+
B cells present are not produced in some cryptic germinal center structures, but rather
belong to a separate population. Conversely, in AID-deficient patients in which germinal
centers are formed but B cells are unable to activate hypermutation and isotype switching,
there is an expansion of the circulating IgM-only CD27+ cells, which can amount to 10% of
their total B cells whereas such cells are extremely minor in normal individuals.
2) Phenotypic analysis and gene expression profiling indicate that blood IgM+IgD+CD27+
cells are circulating marginal zone B cells.
3) After vaccination with a non-conjugated pneumococcal vaccine, blood and splenic
IgM+IgD+CD27+ B cells are specifically mobilized in T-independent responses. This
response is taken care of by mutated antibodies. Upon expansion of these cells in the
splenic marginal zone during the week following vaccination, the hypermutation process
seems to be reactivated.
4) Most strikingly, the blood IgM+IgD+CD27+ B cell population was well expanded and
mutated in children below two years, an age at which toddlers do not respond to T-
independent antigens, thus strongly suggesting that this diversification results at this stage
from a developmental program and not from an immune response.
Our conclusion from these preliminary investigations was, as proposed in our first
report19, that this so-called memory IgM+IgD+CD27+ B cell population, which represent 10-
30% of B cells in blood and spleen, belonged to a different pathway of differentiation and
was linked to the response against TI-antigens. A similar conclusion was reached by
Carsetti and her colleagues in a recent report, based on their study on the responding
8capacity of normal individuals and asplenic or splenectomized patients to T-independent
pneumococcal antigens21.
What can be concluded from this first series of results? We would like to propose
that during early ontogeny blood IgM+IgD+CD27+ B cells develop and mutate their Ig
receptor before 2 years of age, at which stage they become functionally competent against
TI antigens, this competence being probably caused by the differentiation of the
appropriate accessory cells in the splenic marginal zone microenvironment (fig. 1).
But how is this population produced and diversified throughout life? It may either
be maintained in the periphery after its initial production and thus constitute like mouse
B1 cells a separate self-renewing B cell lineage with a large repertoire of specificities and
affinities22,23. Alternatively and more likely, it may be continuously produced, sharing up
to a certain stage a common pathway of differentiation with conventional B cells. At the
transitional bifurcation step, it could be driven by self or bacterial antigens and by specific
interactions with neighboring cells to its final marginal zone B cell phenotype24-26. As
shown for GALT species, these ligands, whether internal or provided by commensal
bacteria, would only induce the proliferation and Ig diversification of these B cells and
would not trigger any effector function, i.e. the production of antibodies. This pre-
diversification step, rather than in B cell follicles along the gut, could take place in the
splenic marginal zone, or in the marginal zone-like regions of tonsils, lymph nodes, and
Peyer’s patches. Asplenic patients indeed harbor IgM+IgD+CD27+ B cells with normally
mutated genes but their frequency appears somewhat reduced in the adults, suggesting
that such marginal zone-like sites, if they can compensate for the diversification function
of the spleen, are not able to support the production and/or survival of these cells to the
same extent.
There are some apparent differences among GALT species that may confuse the
picture. In chickens and sheep, diversification of the pre-immune repertoire starts in the
sterile environment of the embryo and then goes on for several months under the
proliferative stimulation of the gut bacterial constituents. In rabbits, diversification of the B
cell repertoire requires the gut constituents since it starts only after birth, but here again
their role is essentially to drive B cell proliferation. In humans, as it occurs in rabbits, there
is little expansion and diversification of the IgM+IgD+CD27+ B cells at birth, and by 2 years
of age, the frequency of mutations carried by these cells is more or less equivalent to the
one found in adults, suggesting that each new wave of cells undergoes the same
diversification process. What drives pre-diversification of marginal zone B cells in humans
and how does it occur is one of the next burning question.
9B cells thus appear to possess the intrinsic property to diversify their Ig receptor
outside the strict engagement of their B-cell receptor. Strikingly, this has been shown
recently to occur in the mouse under specific experimental conditions: one of these
settings corresponds to a situation of strong germline repertoire restriction, leading to pre-
immune diversification by hypermutation27; the second one to a constitutive B cell
signaling, turning on hypermutation in the context of a microbial-driven, non BCR-
mediated, stimulation28.
In conclusion, this model of differentiation for human marginal zone B cells that
includes a pre-diversification step provides an explanation for the surprising fact that T-
independent responses in humans are taken care by mutated antibodies. It also shows that
humans may have conserved for one arm of their B cell system, in its normal physiological
function, the strategies used by GALT species to diversify their pre-immune repertoire.
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Figure legend
Figure 1. A proposed scheme for the diversification of human marginal zone B cells.
Marginal zone is schematized in light gray, surrounding a primary follicle or a germinal
center (GC). B cells within this environment undergo repertoire diversification, driven by
antigenic stimuli in the absence of antigenic response before two years (the scale of grays
represents an increasing V gene diversity). As the marginal zone environment matures, B
cells become able to respond to T-independent antigens by differentiating into antibody-
secreting cells while possibly triggering another round of diversification by
hypermutation. It is also proposed that newly produced B cells are constantly driven to
diversify outside of an immune response by antigenic stimuli, in a process similar to the
one occurring in young children.
Table 1. Characteristics of B cell diversification in GALT
Chicken Sheep Rabbit
Tissue involved in pre-immune
repertoire formation
Bursa of Fabricius Ileal Peyer’s patches Appendix
Molecular mechanism involved
in the formation of the pre-
immune repertoire
Gene conversion Somatic mutation Gene conversion and somatic
mutation
Development before birth Yes Yes No
Involution at adult stage Yes Yes No
Function Primary lymphoid organ Primary lymphoid organ Primary, then secondary lymphoid
organ
Role of exogenous antigens
after birth
Stimulation of
proliferation
Stimulation of proliferation
(no effect on diversification observed
in germfree sheep or in sterile ileal
segments)
Stimulation of proliferation
(necessary for development after
birth))
Repertoire diversification
(0-2 years)
Repertoire diversification and immune response
(after 2 years)
bacterial or self antigen-driven
diversification
(immature microenvironment)
bacterial or self antigen-driven
diversification
plasmocytes
GC or
primary follicle
T-independent
antigen-specific response
(mature microenvironment,
MΦ, DC, NK-T)
Marginal zone
Figure 1
